Based on our results, miR-495 could effectively prevent high glucose-induced pro-inflammatory and pro-fibrotic effects in human CFs, so the high glucose-stimulated NF-κB and TGF-β1/Smad signaling pathways were analyzed in human CFs. The gene discussed is NFKB1; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.